Whole-genome doubling drives oncogenic loss of chromatin segregation.

Détails

Ressource 1Télécharger: 41586_2023_Article_5794.pdf (19404.50 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_4691B7A968A0
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Whole-genome doubling drives oncogenic loss of chromatin segregation.
Périodique
Nature
Auteur⸱e⸱s
Lambuta R.A., Nanni L., Liu Y., Diaz-Miyar J., Iyer A., Tavernari D., Katanayeva N., Ciriello G. (co-dernier), Oricchio E.
ISSN
1476-4687 (Electronic)
ISSN-L
0028-0836
Statut éditorial
Publié
Date de publication
03/2023
Peer-reviewed
Oui
Volume
615
Numéro
7954
Pages
925-933
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
Whole-genome doubling (WGD) is a recurrent event in human cancers and it promotes chromosomal instability and acquisition of aneuploidies <sup>1-8</sup> . However, the three-dimensional organization of chromatin in WGD cells and its contribution to oncogenic phenotypes are currently unknown. Here we show that in p53-deficient cells, WGD induces loss of chromatin segregation (LCS). This event is characterized by reduced segregation between short and long chromosomes, A and B subcompartments and adjacent chromatin domains. LCS is driven by the downregulation of CTCF and H3K9me3 in cells that bypassed activation of the tetraploid checkpoint. Longitudinal analyses revealed that LCS primes genomic regions for subcompartment repositioning in WGD cells. This results in chromatin and epigenetic changes associated with oncogene activation in tumours ensuing from WGD cells. Notably, subcompartment repositioning events were largely independent of chromosomal alterations, which indicates that these were complementary mechanisms contributing to tumour development and progression. Overall, LCS initiates chromatin conformation changes that ultimately result in oncogenic epigenetic and transcriptional modifications, which suggests that chromatin evolution is a hallmark of WGD-driven cancer.
Mots-clé
Humans, Chromatin/genetics, Chromatin/metabolism, Chromosome Aberrations, Neoplasms/genetics, Chromosomes, Human/genetics, Genome, Human/genetics, Chromosome Segregation/genetics, Carcinogenesis/genetics, Epigenesis, Genetic, Disease Progression, Transcription, Genetic, Gene Expression Regulation, Neoplastic
Pubmed
Open Access
Oui
Création de la notice
24/03/2023 12:15
Dernière modification de la notice
06/08/2024 6:02
Données d'usage